Programme

Programme subject change as details are confirmed. Current as at 16 October.

Time	Session
8.00am - 5.30pm	Registration open
9.00am	Powhiri (Formal welcome to Tāmaki Makaurau Auckland)
10.00am	Morning tea
10.30am	Special Interest Group (SIG) meetings Lung Oncology Digital Pathology Colorectal Carcinogenesis Gynaecological Cancer League
12.00pm	Lunch
12.00pm	Roche Lunch Symposium Lung cancer: find it early and cure it Speakers: Dr Laird Cameron, Auckland City Hospital Prof Sue Crengle, University of Otago Dr Christine Goh, Auckland City Hospital Anne Fraser, Auckland City Hospital
1.00pm	Special Interest Group (SIG) meetings ctDNA and Plasma Genomics Geriatric Oncology Melanoma Research and Therapy Breast Cancer Collaborative Research
2.30pm	Afternoon tea
3.00pm	Special Interest Group (SIG) meetings Gastrointestinal Supportive Cancer Care Tumour Microenvironment GBD (Global Burden of Disease) Oceania Cancer Risk Factor
4.30pm	Biobank panel Human Tissue for Cancer Research Panel: Practicalities and Considerations Chairs: Prof Cris Print and A/Prof Cherie Blenkiron Panel: Dr Nadine Caron, Helen Morrin, Prof Jonathan Koea
5.30pm -7.30pm	Early career networking function Kindly sponsored by Merck

Time	Session
7.00am - 5.30pm	Registration desk open
8.00am	Mihi and President’s Welcome
8.30am	He Akoranga Whakahoungia Chair: Dr Kimiora Henare, A/Prof George Laking Mārire Goodall Keynote: Is the profession changing us? Or are we changing the profession? Perspectives of an Indigenous Surgeon on Turtle Island Prof Nadine Caron, University of British Columbia Hāpai te Hauora: Maximizing opportunities for Māori engagement in clinical trials Prof Natalie Walker and Mary-Kaye Wharakura Hei Āhuru Mōwai (Māori Cancer Leadership Aotearoa) Prof Jonathan Koea
10.30am	Morning tea Kindly sponsored by SunPharma
	Cellular Neighbourhoods
11.00am 11.10am	Chair introduction A/Prof Sharon Pattison & Dr Dean Singleton Why liver metastases are so hard to treat with immunotherapy Dr Erik Sahai, Francis Crick Institute, London
11.40am	Preventing colorectal cancer in NZ - the case for selenium A/Prof Michael Jameson, Te Whatu Ora Waikato
	Connecting Minds - Abstracts
12.00pm	Spatially Defined Intratumoral Immune Response Signatures in Resected Early-Stage Non-Small Cell Lung Cancer Predict Recurrent versus Second Primary Tumors Prof Ping Yang, Mayo Clinic
12.10pm	Bruce Cain Memorial Prof Lai-Ming Ching, University of Auckland
12.15pm	Integrative approaches to identifying new causes of familial breast cancer Prof Ian Campbell, Peter MacCallum Cancer Centre
12.50pm 1.00pm	Lunch Kindly sponsored by SunPharma AstraZeneca symposium HER2-expression in Breast Cancer: Navigating Emerging Therapies and Their Impact in NZ Chair: Dr Dylan Turner Speakers: Prof Stephen Fox, Dr Annette Lasham and Dr Mike McCrystal
2.00pm	Connecting Minds: Pharmac Emerging Researcher Awards Chair: Dr Ben Lawrence
	Analysis of frequency and associations between cancer-associated fibroblasts and T cells in colorectal cancer patients using novel high-dimensional imaging technologies Rory Costello, University of Otago
	The association of desmoplasia with survival in gastric cancer Florence De Roo, University of Otago
	An equitable approach to colorectal cancer detection via cell-free DNA sequencing Michael Dunnet, University of Otago
	SHOC2: a genetic dependency in NRAS-mutant melanoma Andrea Gu, University of Auckland
	Te Rōpū Kāwanatanga – Establishing a Māori Governance Group for a Northern Region Māori Lung Cancer Cohort (MLCC) Stella Williams-Terei & Te Hao Apaapa-Timu, Te Whatu Ora Waitematā
	Human Monocyte Reprogramming by Obesity-Related Compounds Ben Topham, University of Otago
3.15pm	Afternoon tea Kindly sponsored by SunPharma
	Talanoa - Pacific Voices on Cancer Chair: Dr Rob McNeill
3.45pm	Panel presentations and discussion Cancer Status of Pacific Peoples in Aotearoa Dr David Schaaf, Te Aho O Te Kahu Cancer Control Agency Dr Rachel Dyer-Bare, Ministry of Health Nalei Taufa, University of Auckland
4.45pm	Demonstrating the potential of equity-focused cancer screening/early detection interventions to address the life expectancy gap Dr Karen Bartholomew, Te Whatu Ora
5.15pm - 7.00pm	Welcome reception and Poster session Kindly sponsored by Lilly

Time	Session
7.00am - 3.30pm	Registration desk open
7.30am - 8.45am	MSD Breakfast symposium Management of Immunotherapy Toxicity – the NZ context Chair: Dr Peter Fong Speaker: Dr Gareth Rivalland, Dr Annie Wong
	Precision Oncology
9.00am 9.10am	Chair introduction Dr Daisy Mak and Dr Anassuya Ramachandran Ensuring Accessibility, Affordability and Sustainability in Precision Dr. Herbert Loong, Chinese University of Hong Kong
9.40am	Targeting the tumour microenvironment to improve radiotherapy response for head and neck cancers Prof Mahvash Tavassoli, King's College London - Guy's Hospital
	Connecting Minds - Abstracts
10.00am	Defining the antitumour effects of PHD inhibition in melanoma models Claire Palma, Auckland Cancer Society Research Centre
10.10am	IDH1R132H expression alters the metabolic and immune suppressive activity of a novel low grade glioma model. A/Prof Melanie McConnell, Te Herenga Waka Victoria University of Wellington
10.20am	Genetic test development for Oncology at Canterbury Health Laboratories: the process, the problems and insights for a nationally coordinated approach Vivienne Bickley, Canterbury Health Laboratories, Te Whatu Ora
10.30am	Morning tea Kindly sponsored by SunPharma
	Biomarker discovery
11.00am 11.10am	Chair introduction Dr Peter Fong and A/Prof Stephen Jamieson The clinical utility of genomics in cancer diagnostics: therapy, tumour classification and discovery Prof Stephen Fox, Peter MacCallum Cancer Centre
11.40am	Hereditary diffuse gastric cancer: The evolution of a cancer syndrome Prof Parry Guilford, University of Otago
	Connecting Minds - Abstracts
12.00pm	A Promising Pilot – AKT and Autophagy Inhibition in Murine Models of Early and Advanced Gastric Cancer Kate McElroy, University of Otago
12.10pm	Investigating gene dependence in IDH1 mutant glioma using functional genomics Dr Dean Singleton, Auckland Cancer Society Research Centre
12.20pm	THYmine2: Phenotyping for dihydropyrimidine dehydrogenase deficiency and risk of severe to life threatening 5-fluorouracil (5-FU) toxicity in Aotearoa-New Zealand patients Prof Nuala Helsby, University of Auckland
12.30pm	Lunch Kindly sponsored by SunPharma
	Session seven Chairs: Dr Annie Wong and Dr Rachel Purcell
1.30pm	Presentation of the Bridget Robinson Award
1.40pm	Bridget Robinson Award Lecture Prof Mark Elwood
2.10pm	Building a Cancer Clinical Research Network for Aotearoa NZ A/Prof Michael Jameson Dr Nina Scott
2.30pm	CanShare and Research John Fountain, Te Aho o Te Kahu – Cancer Control Agency Jo Paddison, Te Aho o Te Kahu – Cancer Control Agency
	Connecting Minds - Abstracts
2.50pm	The Centralisation Problem: The complex impact of cancer treatment centralisation on equity of access to care A/Prof Jason Gurney, University of Otago
3.00pm	Impact of COVID-19 on cancer patients: mortality, severity and consequences on anti-cancer treatment. A New Zealand retrospective cohort study Claire Harris, Te Pūriri o Te Ora, Te Toka Tumai
3.10pm	Introducing the Roche Translational Cancer Research Fellowship Award Dr Kerryn Symons, Roche NZ Country Medical Director
3.20pm	2023 Roche Translational Cancer Research Fellowship recipient presentation Dr Arthur Morley Bunker, University of Otago
3.40pm	Conference closing
3.45pm	NZSO AGM
6.30pm - midnight	Conference dinner and awards Theme: Connecting with colleagues Princes Ballroom, Pullman Hotel